News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories

NCATS Team Creates Novel Computational Pipeline to Find New Ways to Treat Glioblastoma
March 10, 2025 - NCATS News
- Analytical Chemistry
- Biomedical Data Translator (Translator)
- Informatics (IFX)
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
NCATS scientists tested a new method that could identify existing drugs effective against glioblastoma, a type of brain cancer that currently has no adequate treatments and a very low five-year survival rate.
Read Article
A Combination of Tests Shows Learning Capabilities of Nonverbal Children with Rare Brain Disorder
February 25, 2025 - NCATS News
- Our Impact on Rare Diseases
- Rare Diseases Clinical Research Network (RDCRN)
NCATS-funded scientists found that a pair of tests can measure nonverbal learning skills and show the cognitive abilities of children with Aicardi-Goutières syndrome. The tests could improve the support and therapy doctors provide.
Read ArticlePartner & Grantee News
Neurostimulation Shows Promise as Potential Alzheimer’s Treatment
March 6, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Study Identifies High Costs of Potentially Unneeded Respiratory Testing in Children
March 6, 2025 - Grantee/Partner News
- Our Impact on Research Operations
AI Model Predicts Risks and Potential Causes of Adolescent Mental Illness
March 5, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
Outcomes of Stretching Exercises After Lingual Frenotomy in Infants: A Prospective, Interventional Study
Clinical and Translational Science Awards (CTSA) Program - April 1, 2025 - International Journal of Pediatric Otorhinolaryngology
Read PublicationA Peptide Derived From Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells From Ovarian Cancer Patients’ Ascites
Clinical and Translational Science Awards (CTSA) Program - March 6, 2025 - Cancers
Read PublicationCross-Species and Mammal-to-Mammal Transmission of Clade 2.3.4.4b Highly Pathogenic Avian Influenza A/H5N1 With PB2 Adaptations
Clinical and Translational Science Awards (CTSA) Program - March 6, 2025 - Nature Communications
Read PublicationPilot Study of a Novel First-Line Protocol (THOP) for Intermediate–Large B-Cell Lymphoma in Dogs
Clinical and Translational Science Awards (CTSA) Program - March 6, 2025 - Veterinary Sciences
Read PublicationEvaluating Major Bleeding Risks With Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
Clinical and Translational Science Awards (CTSA) Program - March 6, 2025 - Pharmacoepidemiology
Read PublicationTracking HIV Persistence Across T Cell Lineages During Early ART-Treated HIV-1-Infection Using a Reservoir-Marking Humanized Mouse Model
Clinical and Translational Science Awards (CTSA) Program - March 6, 2025 - Nature Communications
Read PublicationBispecific Antibodies Targeting the N-Terminal and Receptor Binding Domains Potently Neutralize SARS-CoV-2 Variants of Concern
Clinical and Translational Science Awards (CTSA) Program - March 5, 2025 - Science Translational Medicine
Read PublicationA One-Week Reduced-Carbohydrate Diet to Mitigate Iatrogenic Peripheral Hyperinsulinemia Does Not Improve Insulin Sensitivity or Endothelial Function in a Randomized, Crossover Trial in Patients With Type 1 Diabetes
Clinical and Translational Science Awards (CTSA) Program - March 5, 2025 - Cardiovascular Diabetology
Read PublicationPrediction of Mental Health Risk in Adolescents
Clinical and Translational Science Awards (CTSA) Program - March 5, 2025 - Nature Medicine
Read PublicationLong-Read RNA Sequencing Atlas of Human Microglia Isoforms Elucidates Disease-Associated Genetic Regulation of Splicing
Clinical and Translational Science Awards (CTSA) Program - March 3, 2025 - Nature Genetics
Read Publication